Filing Details

Accession Number:
0001012975-20-000407
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-06 16:05:16
Reporting Period:
2020-05-04
Accepted Time:
2020-05-06 16:05:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1211583 Fennec Pharmaceuticals Inc. FENC Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319998 Southpoint Capital Advisors Lp 1114 Avenue Of The Americas, 22Nd Floor
New York NY 10036
No No Yes No
1378376 Southpoint Gp, Lp 1114 Avenue Of The Americas, 22Nd Floor
New York NY 10036
No No Yes No
1378377 Southpoint Capital Advisors Llc 1114 Avenue Of The Americas, 22Nd Floor
New York NY 10036
No No Yes No
1378378 Southpoint Gp, Llc 1114 Avenue Of The Americas, 22Nd Floor
New York NY 10036
No No Yes No
1378379 Ii Smith John Clark 1114 Avenue Of The Americas, 22Nd Floor
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-04 80,000 $6.25 4,077,214 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The securities are directly held by Southpoint Master Fund, LP for which Southpoint Capital Advisors LP serves as the investment manager and Southpoint GP, LP serves as the general partner. Southpoint Capital Advisors LLC serves as the general partner of Southpoint Capital Advisors LP and Southpoint GP, LLC serves as the general partner of Southpoint GP, LP. John S. Clark II serves as managing member of both Southpoint Capital Advisors LLC and Southpoint GP, LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.